After Hours
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility.
Stocks Info
CRBP belongs to the Healthcare sector of the NASDAQ while operating in the Biotechnology industry. The current market capitalization of Corbus Pharmaceuticals Holdings Inc is $147.97M. A total of 84565.0 shares were traded on the day, compared to an average of 458.46K shares.
In the most recent transaction, Cormorant Asset Management, LP sold 30,029 shares of CRBP for 11.46 per share on Dec 11 ’25. After the transaction, the 10% Owner now owns 2,344,971 company shares. In a previous transaction on Oct 24 ’25, Cohen Yuval sold 18,660 shares at 17.01 per share. CRBP shares that Chief Executive Officer owns now total 138,187.
Among the insiders who sold shares, Cohen Yuval disposed of 8,973 shares on Oct 27 ’25 at a per-share price of $17.14. This resulted in the Chief Executive Officer holding 138,187 shares of CRBP after the transaction. In another insider transaction, Moran Sean F. sold 12,981 shares at $17.02 per share on Oct 24 ’25. Company shares held by the Chief Financial Officer now total 73,313.
While price targets are rarely accurate, they tend to exert some kind of influence from time to time and are often taken into account by investors. In terms of 52-week highs and lows, CRBP has a high of $20.56 and a low of $4.64.
As of this writing, CRBP has an earnings estimate of -$1.6 per share for the current quarter. EPS was calculated based on a consensus of 10.0 estimates, with a high estimate of -$0.94 per share and a lower estimate of -$3.57. The company reported an EPS of -$0.78 in the last quarter
Balance Sheet Annually/Quarterly
An organization’s balance sheet depicts the assets and liabilities it has, as well as the amount of equity invested. Investors can measure a company’s prospects by calculating its financial ratios using this information. CRBP’s latest balance sheet shows that the firm has $97.65M in Cash & Short Term Investments as of fiscal 2021. There were $26.59M in debt and $17.01M in liabilities at the time. Its Book Value Per Share was $7.35, while its Total Shareholder’s Equity was $69.11M.
Analysts Opinion
There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for CRBP is Buy with a score of 4.73.
